Lexicon Pharmaceuticals (LXRX) Interest & Investment Income (2010 - 2023)
Lexicon Pharmaceuticals' (LXRX) quarterly Interest & Investment Income came in at $63000.0 in Q2 2023, up 155.75% year-on-year from $24633.2 in Q2 2022, and down 76.23% on a QoQ basis from $265000.0 in Q1 2023.
Lexicon Pharmaceuticals (LXRX) Interest & Investment Income (2010 - 2023) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 14 years of Interest & Investment Income data on file, last reported at $63000.0 in Q2 2023.
- On a quarterly basis, Interest & Investment Income rose 155.75% year-over-year to $63000.0 in Q2 2023; TTM through Jun 2023 was $50000.0, a 134.25% increase from a year earlier, with the FY2022 full-year figure at -$418000.0, down 10350.0% from the prior year.
- Interest & Investment Income for Q2 2023 stood at $63000.0, down from $265000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for LXRX reached as high as $776000.0 in Q1 2020 and fell as low as -$548000.0 in Q2 2020.
- Historically, Interest & Investment Income has averaged -$4944.4 across 5 years, with a median of -$3000.0 in 2021.
- Across the five-year window, Interest & Investment Income jumped 1624.44% in 2020 and slumped 34000.0% in 2022, its largest moves.
- Year by year, Interest & Investment Income stood at $48000.0 in 2019, then plunged by 185.42% to -$41000.0 in 2020, then surged by 87.8% to -$5000.0 in 2021, then surged by 1360.0% to $63000.0 in 2022, then changed by 0.0% to $63000.0 in 2023.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $63000.0 in Q2 2023, $265000.0 in Q1 2023, and $63000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Lexicon Pharmaceuticals | 922.55 Mn | 751.90 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 63,000.00 |
| Mar 31, 2023 | 265,000.00 |
| Dec 31, 2022 | 63,000.00 |
| Sep 30, 2022 | -341,000.00 |
| Jun 30, 2022 | -113,000.00 |
| Mar 31, 2022 | -27,000.00 |
| Dec 31, 2021 | -5,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -10,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Dec 31, 2020 | -41,000.00 |
| Sep 30, 2020 | -277,000.00 |
| Jun 30, 2020 | -548,000.00 |
| Mar 31, 2020 | 776,000.00 |
| Dec 31, 2019 | 48,000.00 |
| Sep 30, 2019 | -50,000.00 |
| Jun 30, 2019 | 53,000.00 |
| Mar 31, 2019 | 45,000.00 |
| Dec 31, 2018 | 59,000.00 |
| Sep 30, 2018 | 147,000.00 |